NCEL
NewcelX Ltd.
NASDAQ · Healthcare · Biotechnology · CH
$3.35
+0.00%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 0.27x
Liquidity & coverage
- Current ratio
- 0.76x
- Quick ratio
- 0.76x
- Cash ratio
- 0.52x
- Interest coverage
- -1.77x
- EBITDA / interest
- -1.17x
- Working capital
- -$1.0M
Cash & dividend
- FCF / debt
- -17.88x
- Cash flow / debt
- -17.87x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025